Literature DB >> 25193240

Aβ seeds resist inactivation by formaldehyde.

Sarah K Fritschi1, Amarallys Cintron, Lan Ye, Jasmin Mahler, Anika Bühler, Frank Baumann, Manuela Neumann, K Peter R Nilsson, Per Hammarström, Lary C Walker, Mathias Jucker.   

Abstract

Cerebral β-amyloidosis can be exogenously induced by the intracerebral injection of brain extracts containing aggregated β-amyloid (Aβ) into young, pre-depositing Aβ precursor protein- (APP) transgenic mice. Previous work has shown that the induction involves a prion-like seeding mechanism in which the seeding agent is aggregated Aβ itself. Here we report that the β-amyloid-inducing activity of Alzheimer's disease (AD) brain tissue or aged APP-transgenic mouse brain tissue is preserved, albeit with reduced efficacy, after formaldehyde fixation. Moreover, spectral analysis with amyloid conformation-sensitive luminescent conjugated oligothiophene dyes reveals that the strain-like properties of aggregated Aβ are maintained in fixed tissues. The resistance of Aβ seeds to inactivation and structural modification by formaldehyde underscores their remarkable durability, which in turn may contribute to their persistence and spread within the body. The present findings can be exploited to establish the relationship between the molecular structure of Aβ aggregates and the variable clinical features and disease progression of AD even in archived, formalin-fixed autopsy material.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25193240      PMCID: PMC4169116          DOI: 10.1007/s00401-014-1339-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  De novo induction of amyloid-β deposition in vivo.

Authors:  R Morales; C Duran-Aniotz; J Castilla; L D Estrada; C Soto
Journal:  Mol Psychiatry       Date:  2011-10-04       Impact factor: 15.992

2.  Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice.

Authors:  Götz Heilbronner; Yvonne S Eisele; Franziska Langer; Stephan A Kaeser; Renata Novotny; Amudha Nagarathinam; Andreas Aslund; Per Hammarström; K Peter R Nilsson; Mathias Jucker
Journal:  EMBO Rep       Date:  2013-09-03       Impact factor: 8.807

Review 3.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

4.  Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.

Authors:  David J Irwin; Joseph Y Abrams; Lawrence B Schonberger; Ellen Werber Leschek; James L Mills; Virginia M-Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

Review 5.  Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.

Authors:  Iris Delrue; Dieter Verzele; Annemieke Madder; Hans J Nauwynck
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

6.  Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates.

Authors:  Therése Klingstedt; Andreas Aslund; Rozalyn A Simon; Leif B G Johansson; Jeffrey J Mason; Sofie Nyström; Per Hammarström; K Peter R Nilsson
Journal:  Org Biomol Chem       Date:  2011-11-03       Impact factor: 3.876

7.  The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain.

Authors:  Tsuyoshi Hamaguchi; Yvonne S Eisele; Nicholas H Varvel; Bruce T Lamb; Lary C Walker; Mathias Jucker
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

8.  Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.

Authors:  Jan Stöhr; Joel C Watts; Zachary L Mensinger; Abby Oehler; Sunny K Grillo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

Review 9.  Alzheimer disease in 2020.

Authors:  David M Holtzman; Eckhard Mandelkow; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

10.  Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Authors:  Paul Brown; Jean-Philippe Brandel; Takeshi Sato; Yosikazu Nakamura; Jan MacKenzie; Robert G Will; Anna Ladogana; Maurizio Pocchiari; Ellen W Leschek; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

View more
  30 in total

1.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

Review 2.  β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 3.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

4.  Follow-up study of a patient with early onset cerebral amyloid angiopathy following childhood cadaveric dural graft.

Authors:  Kenji Yoshiki; Genjiro Hirose; Kazuhiko Kumahashi; Yukihiko Kohda; Kazunori Ido; Akihiro Shioya; Kouichi Misaki; Kensaku Kasuga
Journal:  Acta Neurochir (Wien)       Date:  2021-02-13       Impact factor: 2.216

Review 5.  Bioassays and Inactivation of Prions.

Authors:  Kurt Giles; Amanda L Woerman; David B Berry; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 6.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

Review 7.  The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.

Authors:  Lary C Walker; Juliane Schelle; Mathias Jucker
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

8.  MSA prions exhibit remarkable stability and resistance to inactivation.

Authors:  Amanda L Woerman; Sabeen A Kazmi; Smita Patel; Yevgeniy Freyman; Abby Oehler; Atsushi Aoyagi; Daniel A Mordes; Glenda M Halliday; Lefkos T Middleton; Steve M Gentleman; Steven H Olson; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2017-08-28       Impact factor: 17.088

9.  Widespread tau seeding activity at early Braak stages.

Authors:  Jennifer L Furman; Jaime Vaquer-Alicea; Charles L White; Nigel J Cairns; Peter T Nelson; Marc I Diamond
Journal:  Acta Neuropathol       Date:  2016-11-22       Impact factor: 17.088

10.  Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.

Authors:  Jasmin Mahler; Jose Morales-Corraliza; Julia Stolz; Angelos Skodras; Rebecca Radde; Carmen C Duma; Yvonne S Eisele; Matthew J Mazzella; Harrison Wong; William E Klunk; K Peter R Nilsson; Matthias Staufenbiel; Paul M Mathews; Mathias Jucker; Bettina M Wegenast-Braun
Journal:  Neurobiol Aging       Date:  2015-03-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.